These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 7001124)

  • 1. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
    Oshimi K; Kano S; Takaku F; Okumura K
    J Natl Cancer Inst; 1980 Dec; 65(6):1265-9. PubMed ID: 7001124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
    Ishida N; Saito M; Nanjo M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2681-90. PubMed ID: 6508321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats.
    Fukui H; Reynolds CW
    J Natl Cancer Inst; 1987 Nov; 79(5):1019-24. PubMed ID: 3500354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the properties of a streptococcal preparation OK-432 (NSC-B116209) as an immunopotentiator. I. Activation of serum complement components and peritoneal exudate cells by group A streptococcus.
    Sakai S; Ryoyama K; Koshimura S; Migita S
    Jpn J Exp Med; 1976 Apr; 46(2):123-33. PubMed ID: 778447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased natural killer cell activity in experimental American trypanosomiasis.
    Hatcher FM; Kuhn RE; Cerrone MC; Burton RC
    J Immunol; 1981 Sep; 127(3):1126-30. PubMed ID: 6790614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific cytotoxicity of vaccinia-induced peritoneal exudates in hamsters is mediated by Thy-1.2 homologue-positive cells distinct from NK cells and macrophages.
    Yang H; Tompkins WA
    J Immunol; 1983 Nov; 131(5):2545-50. PubMed ID: 6195269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
    Shitara K; Ichimura O; Mitsuno T; Osawa T
    J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced generation of OK-432-induced killer cells by interleukin 2.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):183-8. PubMed ID: 3500332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined effect of intraperitoneally administered OK-432 and recombinant interleukin (rIL-2) against mouse tumors].
    Fujioka T; Shiraishi M; Tanji S; Koike H; Kumagai K; Kubo T; Ohhori T
    Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):948-56. PubMed ID: 2789265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
    Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
    Stein-Streilein J; Bennett M; Mann D; Kumar V
    J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A glycolipid on the surface of mouse natural killer cells.
    Kasai M; Iwamori M; Nagai Y; Okumura K; Tada T
    Eur J Immunol; 1980 Mar; 10(3):175-80. PubMed ID: 6966574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG.
    Shimada S; Yano O; Tokunaga T
    Jpn J Cancer Res; 1986 Aug; 77(8):808-16. PubMed ID: 2428798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
    J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
    Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
    J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive immunotherapy in tumor-bearing mice with OK-432-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1988 Apr; 58(2):109-14. PubMed ID: 3261814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.
    Kalland T; Alm G; Stålhandshe T
    J Immunol; 1985 Jun; 134(6):3956-61. PubMed ID: 2580900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].
    Mizushima Y; Hirata H; Sakamoto K; Sato M; Morikage T; Maruyama M; Sasaki K; Yano S
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2710-5. PubMed ID: 3631971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.
    Saito M; Ichimura O; Kataoka M; Moriya Y; Ueno K; Sugawara Y; Nanjo M; Ishida N
    Cancer Immunol Immunother; 1986; 22(3):161-8. PubMed ID: 2425968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.